Goff BA - Search Results

1

Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer.

Ghezelayagh TS, Kohrn BF, Fredrickson J, Manhardt E, Radke MR, Katz R, Gray HJ, Urban RR, Pennington KP, Liao JB, Doll KM, Simons EJ, Burzawa JK, Goff BA, Speiser P, Swisher EM, Norquist BM, Risques RA. Ghezelayagh TS, et al. Among authors: goff ba. Cancer Res Commun. 2022 Oct;2(10):1282-1292. doi: 10.1158/2767-9764.crc-22-0314. Epub 2022 Oct 27. Cancer Res Commun. 2022. PMID: 36311816 Free PMC article.

2

The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.

Swisher EM, Gown AM, Skelly M, Ek M, Tamimi HK, Cain JM, Greer BE, Muntz HG, Goff BA. Swisher EM, et al. Among authors: goff ba. Gynecol Oncol. 1996 Jan;60(1):81-8. doi: 10.1006/gyno.1996.0015. Gynecol Oncol. 1996. PMID: 8557233

3

Ovarian carcinoma diagnosis.

Goff BA, Mandel L, Muntz HG, Melancon CH. Goff BA, et al. Cancer. 2000 Nov 15;89(10):2068-75. doi: 10.1002/1097-0142(20001115)89:10<2068::aid-cncr6>3.0.co;2-z. Cancer. 2000. PMID: 11066047

4

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA. Paley PJ, et al. Among authors: goff ba. Gynecol Oncol. 2001 Feb;80(2):176-80. doi: 10.1006/gyno.2000.6071. Gynecol Oncol. 2001. PMID: 11161856

5

Use of complementary and alternative medicine among women with gynecologic cancers.

Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG. Swisher EM, et al. Among authors: goff ba. Gynecol Oncol. 2002 Mar;84(3):363-7. doi: 10.1006/gyno.2001.6515. Gynecol Oncol. 2002. PMID: 11855870

6

Glassy cell carcinoma of the cervix revisited.

Gray HJ, Garcia R, Tamimi HK, Koh WJ, Goff BA, Greer BE, Paley PJ. Gray HJ, et al. Among authors: goff ba. Gynecol Oncol. 2002 May;85(2):274-7. doi: 10.1006/gyno.2001.6523. Gynecol Oncol. 2002. PMID: 11972387

7

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Leeper K, et al. Gynecol Oncol. 2002 Oct;87(1):52-6. doi: 10.1006/gyno.2002.6779. Gynecol Oncol. 2002. PMID: 12468342

8

The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L, Goff B. Everett E, et al. Gynecol Oncol. 2003 Jul;90(1):150-7. doi: 10.1016/s0090-8258(03)00232-4. Gynecol Oncol. 2003. PMID: 12821356

9

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer.

Swisher EM, Wollan M, Mahtani SM, Willner JB, Garcia R, Goff BA, King MC. Swisher EM, et al. Among authors: goff ba. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):662-7. doi: 10.1016/j.ajog.2005.01.054. Am J Obstet Gynecol. 2005. PMID: 16150257

10

Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.

Shah C, Johnson EB, Everett E, Tamimi H, Greer B, Swisher E, Goff B. Shah C, et al. Gynecol Oncol. 2005 Dec;99(3):564-70. doi: 10.1016/j.ygyno.2005.06.011. Epub 2005 Oct 24. Gynecol Oncol. 2005. PMID: 16246402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters